ATE144900T1 - Verwendung von xanthinderivaten gegen magengeschwüre - Google Patents

Verwendung von xanthinderivaten gegen magengeschwüre

Info

Publication number
ATE144900T1
ATE144900T1 AT90115456T AT90115456T ATE144900T1 AT E144900 T1 ATE144900 T1 AT E144900T1 AT 90115456 T AT90115456 T AT 90115456T AT 90115456 T AT90115456 T AT 90115456T AT E144900 T1 ATE144900 T1 AT E144900T1
Authority
AT
Austria
Prior art keywords
xanthine derivatives
stomach ulcer
derivatives against
against stomach
alkyl
Prior art date
Application number
AT90115456T
Other languages
English (en)
Inventor
Toshizo Tanaka
Shoryo Hayashi
Yuko Morioka
Ulrich Dr Gebert
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE144900T1 publication Critical patent/ATE144900T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT90115456T 1989-08-16 1990-08-11 Verwendung von xanthinderivaten gegen magengeschwüre ATE144900T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21018789 1989-08-16

Publications (1)

Publication Number Publication Date
ATE144900T1 true ATE144900T1 (de) 1996-11-15

Family

ID=16585226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90115456T ATE144900T1 (de) 1989-08-16 1990-08-11 Verwendung von xanthinderivaten gegen magengeschwüre

Country Status (18)

Country Link
US (1) US5109003A (de)
EP (1) EP0413278B1 (de)
JP (1) JP2977242B2 (de)
KR (1) KR910004620A (de)
AT (1) ATE144900T1 (de)
AU (1) AU624987B2 (de)
CA (1) CA2023310A1 (de)
DD (1) DD298051A5 (de)
DE (1) DE69029069T2 (de)
DK (1) DK0413278T3 (de)
ES (1) ES2094132T3 (de)
GR (1) GR3021569T3 (de)
HU (1) HU207518B (de)
IE (1) IE902954A1 (de)
IL (1) IL95377A (de)
NZ (1) NZ234896A (de)
PT (1) PT95007A (de)
ZA (1) ZA906446B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5354756A (en) * 1993-01-12 1994-10-11 Cell Therapeutics, Inc. Olefin-substituted long chain xanthine compounds
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IL106854A (en) * 1986-12-31 1996-05-14 Hoechst Roussel Pharma Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
EP0413278A3 (en) 1992-05-06
EP0413278B1 (de) 1996-11-06
DD298051A5 (de) 1992-02-06
HUT54688A (en) 1991-03-28
IE902954A1 (en) 1991-02-27
DE69029069D1 (de) 1996-12-12
GR3021569T3 (en) 1997-02-28
IL95377A0 (en) 1991-06-30
KR910004620A (ko) 1991-03-29
EP0413278A2 (de) 1991-02-20
ZA906446B (en) 1991-05-29
ES2094132T3 (es) 1997-01-16
JPH03163019A (ja) 1991-07-15
NZ234896A (en) 1993-10-26
AU6101890A (en) 1991-02-21
AU624987B2 (en) 1992-06-25
DK0413278T3 (da) 1997-04-07
DE69029069T2 (de) 1997-04-10
US5109003A (en) 1992-04-28
IL95377A (en) 1994-08-26
PT95007A (pt) 1991-04-18
HU905000D0 (en) 1991-01-28
HU207518B (en) 1993-04-28
JP2977242B2 (ja) 1999-11-15
CA2023310A1 (en) 1991-02-17

Similar Documents

Publication Publication Date Title
NO892058L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzamider.
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
DE69222459D1 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
DE3879258D1 (de) Praeparat gegen ulcus.
DK671688D0 (da) 2-(piperazinyl)-2-oxoethylensubstituerede flavonoidderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK147588A (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
IL89324A0 (en) Therapeutic agents for the treatment of peptic ulcer disease containing xanthine derivatives
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
EP0266559A3 (en) Therapeutic agent for the treatment of peptic ulcer disease
NO893039L (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee